GlassScriptPhysician profile
David Horovitz
NPI 1013309947
$4,438.81
in general payments reported to CMS, 2019-2025
35 companies · $463 in 2025
The $463 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $895 · 2020: $1,169 · 2021: $350 · 2022: $573 · 2023: $379 · 2024: $611 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,452.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,058.75 | 2019-2025 | Altis |
| Axonics, INC. | $840.38 | 2020-2024 | Axonics, Bulkamid |
| Medtronic USA, INC. | $820.11 | 2019-2020 | |
| Boston Scientific Corporation | $201.73 | 2019-2025 | Axonics |
| Urogen Pharma, INC. | $186.64 | 2020-2025 | |
| Janssen Biotech, INC. | $165.84 | 2022-2025 | Erleada |
| Abbvie INC. | $151.82 | 2020-2025 | |
| Astellas Pharma US INC | $105.99 | 2022-2023 | Myrbetriq |
| Teleflex LLC | $89.00 | 2021-2025 | Barrigel |
| Smith+Nephew, INC. | $84.57 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $79.70 | 2020-2022 | |
| Olympus America INC. | $66.19 | 2022-2025 | Itind System |
| 180 Medical, INC. | $51.19 | 2023 | Cure Catheter |
| Photocure INC | $45.22 | 2020 | |
| Myriad Genetic Laboratories, INC. | $43.81 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $42.57 | 2023 | |
| Immunitybio, INC. | $33.14 | 2024 | |
| Karl Storz Endoscopy-America | $32.77 | 2024 | Hopkins |
| Vertex Pharmaceuticals Incorporated | $29.89 | 2025 | |
| Becton, Dickinson and Company | $27.87 | 2023 | Bard Urinary Drainage Bag |
| Dendreon Pharmaceuticals LLC | $24.84 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $24.77 | 2025 | |
| Conmed Corporation | $24.62 | 2024 | Airseal |
| Blue Earth Diagnostics | $23.80 | 2021 | |
| Innovation Technologies INC | $23.30 | 2023 | Irrisept |
| Ferring Pharmaceuticals INC. | $19.55 | 2025 | Adstiladrin |
| Accord Healthcare, INC. | $18.89 | 2024 | |
| Travere Therapeutics, INC. | $18.04 | 2021 | |
| Antares Pharma, INC. | $17.88 | 2025 | Xyosted |
| Procept Biorobotics Corporation | $16.60 | 2025 | |
| Laborie Medical Technologies Corp. | $15.57 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $15.11 | 2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $14.24 | 2021 | |
| Agiliti Surgical, INC. | $12.70 | 2022 | |
| Hologic Sales and Service, LLC | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Horovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.